Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease

Clinical and Experimental Nephrology

Volumn 19, Issue 3, 2015, Pages 371-378

  Sueta, Shinichi ^a   Morozumi, Kunio ^a   Takeda, Asami ^a   Horike, Keiji ^a   Otsuka, Yasuhiro ^a   Shinjo, Hibiki ^a   Murata, Minako ^a   Kato, Yuki ^a   Goto, Kazunori ^a   Inaguma, Daijo ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Chronic kidney disease; Congestive heart failure; Vitamin D receptor activator

Indexed keywords

UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR ACTIVATOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREVALENCE; PULSE PRESSURE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY; AGED; AGONISTS; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; PULMONARY EDEMA; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY EDEMA; RECEPTORS, CALCITRIOL; REGRESSION ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 84931004607     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-0994-x     Document Type: Article

References (21)

1. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:208.
2. LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45:1026–33.
3. Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R. Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol. 2010;5:460–7.
4. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9.
5. Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;9:650–6.
6. Jones G. Expanding role of vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1α-hydroxylase in the classical and nonclassical actions of 1α,25-dihydroxyvitamin D3. Semin Dial. 2007;20:316–24.
7. Mehrotra R, Kermah DA, Salusky IB. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009;76:977–83.
8. De Boer I, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25(OH)D levels and albuminuria in the Third National Health and Nutrition Examination Survey(NHANES III). Am J Kidney Dis. 2007;50:69–77.
9. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;11:1159–65.
10. Liu LC, Voors AA, Van Veldhuisen DJ, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011;13:615–25.
11. Fernández-Juárez G, Luño J, Barrio V, et al. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol. 2013;8:1870–6.
12. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72:1004–13.
13. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
14. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152:315–23.
15. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003;88:327–31.
16. Kilickesmez KO, Abaci O, Okcun B. Chronic kidney disease as a predictor of coronary lesion morphology. Angiology. 2010;61:344–9.
17. Patange AR, Valentini RP, Gothe MP, Du W, Pettersen MD. Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease. Pediatr Cardiol. 2013;34:536–42.
18. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011;6:50–62.
19. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Eng J Med. 2003;31:446–56.
20. Tentori F, Hunt WC, Stidley CA. For the medical directors of Dialysis Clinic Inc: mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 2006;70:1858–65.
21. Miller JE, Molnar MZ, Kovesdy CP, et al. Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012;21:1232–9.